Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,287 public trials 1,279 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Active, Not Recruiting

Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

NCT01892397

Conditions
Brain Cancer, Brain Diseases, Brain Neoplasms, +11 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Colorado Denver, Colorado, United States
  • University of Miami Miami, Florida, United States
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
View Trial Details
Active, Not Recruiting

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

NCT05608291

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • UC San Diego La Jolla, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • John Wayne Cancer Institute (JWCI) Santa Monica, California, United States
  • The Melanoma And Skin Cancer Institute Englewood, Colorado, United States
View all 211 locations
View Trial Details
Active, Not Recruiting

Open-Label Study of 18F-mFBG for Imaging Neuroblastoma

NCT04724369

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Riley Hospital for Children - Indiana University Indianapolis, Indiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

NCT07023731

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +61 more
Locations
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site New Haven, Connecticut, United States
  • Clinical Trial Site Tampa, Florida, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

NCT03375320

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +42 more
Locations
  • Katmai Oncology Group Anchorage, Alaska, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 433 locations
View Trial Details
Active, Not Recruiting

Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

NCT01841736

Conditions
Foregut Neuroendocrine Tumor, Hindgut Neuroendocrine Tumor, Metastatic Digestive System Neuroendocrine Tumor G1, +11 more
Locations
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
View all 423 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

NCT06388733

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ivy Brain Tumor Center Phoenix, Arizona, United States
  • Scripps Cancer Center La Jolla, California, United States
  • Moores UCSD Cancer Center La Jolla, California, United States
View all 95 locations
View Trial Details
Active, Not Recruiting

Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)

NCT04195555

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, Female Urogenital Diseases, +80 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 174 locations
View Trial Details

Related conditions